Cart
Shopping cart
Press releases - Thursday, April 4, 2024 10:00 AM CET

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2024

Zinzino group revenue increased with a total of 14 % in Q1 compared with the previous year.

The revenue in March for Zinzino's sales markets increased by 9% and amounted to SEK 148.9 (136.2) million. Faun Pharma's external sales decreased with 1 % and amounted to SEK 9.7 (9.8) million. Overall, the Group increased revenues by 9% to SEK 158.6 (146.0) million compared with the previous year.

The group revenue increased with 14 % for Q1 2024 compared with the first quarter last year and amounted to SEK 450.4 (393.7) million.

Revenues were distributed as follows:

Regions, mSEK 24-mar 23-mar Change Q1 2024 Q1 2023 Change
The Nordics 22.6 26.8 -16% 66.8 73.6 -9%
Central Europe 41.7 35.5 17% 117.8 90.9 30%
East Europe 32.1 34.6 -7% 93.3 92.5 1%
South & West Europe 25.7 18.7 37% 70.7 49,0 44%
The Baltics 7.9 7.7 3% 23.6 21.1 12%
North America 12.7 7,0 81% 34.7 19.6 77%
Asia-Pacific 5,0 4.5 11% 12.7 15.6 -19%
Africa 1.2 1.4           -14% 3.3 3.8           -13%
Zinzino 148.9 136.2 9% 422.9 366.1 16%
Faun Pharma 9.7 9.8 -1% 27.5 27.6 0%
Zinzino Group 158.6 146.0 9% 450.4 393.7 14%

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)